Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Qiagen announces positive second quarter results

Qiagen announces positive second quarter results

12th August 2010

Qiagen has highlighted its solid financial performance in the second quarter of 2010, after recording a nine per cent year-on-year increase in net sales.

The science company's consolidated net sales total for the quarter came to $262.7 million (168.4 million pounds), contributing to a 14 per cent growth in overall figures for the first half of the year.

High levels of demand were seen from the applied market, pharmaceutical and academic sectors during the quarter, while the molecular diagnostics industry was noted as the company's "strongest revenue driver".

Peer Schatz, Qiagen's chief executive officer, expressed confidence that future growth will be underpinned by the recent launch of a number of assay products and its new SABiosciences portfolio.

He added: "We feel very well prepared to take advantage of the growth opportunities in our target markets and are on track to achieve our annual targets."

Last month, Qiagen announced the appointment of Dr Ellen Sheets as its chief medical officer, heading the firm's research into cancer biomarkers.ADNFCR-8000103-ID-800022658-ADNFCR

We currently have 9 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.